Prothena (PRTA) Q1 Earnings Miss Estimates on Higher R&D Expenses [Yahoo! Finance]
Prothena Corporation plc - Ordinary Shares (PRTA)
Last prothena corporation plc - ordinary shares earnings: 2/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.prothena.com
Company Research
Source: Yahoo! Finance
The figure was also wider than a loss of 89 cents in the year-ago quarter due to higher expenses and lower revenues. Total revenues were $0.05 million in the first quarter, missing the Zacks Consensus Estimate of $4 million and declining from $2.2 million in the year-ago quarter. Total revenues in the first quarter were from license fees recognized under an agreement with Roche RHHBY. The same in first-quarter 2023 was generated by a collaboration with Bristol Myers Squibb BMY. The company's shares have lost 36.6% year to date compared with the industry's decline of 5.9%. Image Source: Zacks Investment Research Quarter in Detail Research and development (R&D) expenses surged 43.2% to $64.1 million primarily due to higher clinical trial expenses, higher personnel-related expenses and higher manufacturing expenses. General and administrative expenses amounted to $17.5 million, up from $13.7 million in the year-ago quarter, primarily due to higher personnel-related and cons
Show less
Read more
Impact Snapshot
Event Time:
PRTA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRTA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRTA alerts
High impacting Prothena Corporation plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PRTA
News
- Prothena (PRTA), Bristol Myers Tie Up for Second Neuro Candidate [Yahoo! Finance]Yahoo! Finance
- BMS stakes $80m on Prothena's neurodegenerative candidate [Yahoo! Finance]Yahoo! Finance
- Bristol Myers licenses second compound from Prothena [Seeking Alpha]Seeking Alpha
- Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration [Yahoo! Finance]Yahoo! Finance
- Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development CollaborationBusiness Wire
PRTA
Earnings
- 5/8/24 - Miss
PRTA
Sec Filings
- 5/28/24 - Form 8-K
- 5/17/24 - Form 4
- 5/17/24 - Form 4
- PRTA's page on the SEC website